Bargellini, Irene
 Distribuzione geografica
Continente #
AS - Asia 132
EU - Europa 108
NA - Nord America 81
SA - Sud America 29
AF - Africa 2
Totale 352
Nazione #
US - Stati Uniti d'America 79
SG - Singapore 56
CN - Cina 39
BR - Brasile 29
FR - Francia 26
DE - Germania 24
IN - India 15
IT - Italia 14
IE - Irlanda 12
GB - Regno Unito 8
ID - Indonesia 8
KR - Corea 8
RU - Federazione Russa 6
SE - Svezia 6
FI - Finlandia 4
AT - Austria 3
IQ - Iraq 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BE - Belgio 1
CA - Canada 1
GR - Grecia 1
KG - Kirghizistan 1
MX - Messico 1
NL - Olanda 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 352
Città #
Singapore 40
Ashburn 22
New York 16
Frankfurt am Main 13
Dublin 12
Hyderabad 12
Hefei 10
Jakarta 8
Milan 8
Seoul 8
Los Angeles 5
Düsseldorf 4
Helsinki 4
Lauterbourg 4
Nuremberg 4
Rome 4
London 3
Moscow 3
Roubaix 3
The Dalles 3
Arapiraca 2
Beijing 2
Curitiba 2
Falkenstein 2
Pune 2
São Gonçalo 2
Vienna 2
Washington 2
Wroclaw 2
Amsterdam 1
Anápolis 1
Aparecida de Goiânia 1
Baghdad 1
Barreiras 1
Belo Horizonte 1
Bishkek 1
Boa Esperança do Sul 1
Brussels 1
Cachoeiro de Itapemirim 1
Camaçari 1
Camden 1
Caxias do Sul 1
Chennai 1
Chicago 1
City of Westminster 1
Contagem 1
Dhaka 1
Dubai 1
Ealing 1
El Paso 1
Gloucester 1
Goiânia 1
Guarapari 1
Ibema 1
Indaiatuba 1
Izmir 1
Johannesburg 1
Lanzhou 1
Manchester 1
Mexico City 1
Montreal 1
Mosul 1
Ningbo 1
Olathe 1
Palmas 1
Parauapebas 1
Paulista 1
Porto Alegre 1
Portsmouth 1
Rio de Janeiro 1
Rochester 1
Salvador 1
Santa Clara 1
Santa Luzia 1
Seattle 1
Shanghai 1
Stockholm 1
São José 1
São Paulo 1
Thessaloniki 1
Tunis 1
Várzea Paulista 1
Totale 257
Nome #
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression 42
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib 40
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial 39
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial 35
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial 33
Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives 33
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial 32
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib 32
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients 31
Optimised Tumour Sampling and Processing by a Multidisciplinary Approach for an Accurate Diagnosis in Non-Small Cell Lung Cancer 28
Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma 19
Totale 364
Categoria #
all - tutte 2.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 4 2 6 4 1 1
2023/202482 0 16 5 7 5 27 9 0 1 2 3 7
2024/2025264 8 2 19 12 21 11 15 4 25 43 69 35
Totale 364